机构:[1]Geno-immune Medical Institute, Shenzhen. China.[2]School of Medicine, University of Electronic Science and Technology of China, Sichuan. China.四川省人民医院[3]Hematology Oncology Center, Beijing Children`s Hospital, Capital Medical University, National Center for Children's Health, Beijing. China.医技科室职能科室临床流行病与循证医学中心血液中心首都医科大学附属北京儿童医院[4]Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children`s Health, Beijing. China.医技科室职能科室临床流行病与循证医学中心血液中心首都医科大学附属北京儿童医院[5]PKU-HKUST Shenzhen-Hong Kong Institution, Shenzhen. China.[6]Department of Pediatrics and Division of Hematology/Oncology, and fDepartment Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida. United States.
This study was supported by grants from research funds of Science and Technology Planning Technical Research Project of Shenzhen (JCYJ20170413154349187, JCYJ 20170817172416991, JCYJ 20170817172541842, and KQTD20140630143254906) and UESTC (ZYGX2016Z009 and SQ2016YFSF090567), and Natural Science Foundation of Guangdong Province?No. 2018A030313950).
第一作者机构:[1]Geno-immune Medical Institute, Shenzhen. China.
推荐引用方式(GB/T 7714):
Guo Xiao-Lu,Chung Tsai-Hua,Qin Yue,et al.Hemophilia Gene Therapy: From Bench to Bed Side.[J].CURRENT GENE THERAPY.2019,19(4):doi:10.2174/1566523219666190924121836.
APA:
Guo Xiao-Lu,Chung Tsai-Hua,Qin Yue,Zheng Jie,Zheng Huyong...&Chang Lung-Ji.(2019).Hemophilia Gene Therapy: From Bench to Bed Side..CURRENT GENE THERAPY,19,(4)
MLA:
Guo Xiao-Lu,et al."Hemophilia Gene Therapy: From Bench to Bed Side.".CURRENT GENE THERAPY 19..4(2019)